Valuation: UCB

Market Cap 42.5B 48.89B 39.56B 36.32B 68.58B 4,667B 69.65B 466B 183B 2,323B 184B 180B 7,791B P/E 2026 *
23.4x
P/E 2027 * 18.8x
Enterprise Value 42.45B 48.83B 39.51B 36.28B 68.51B 4,662B 69.57B 466B 183B 2,321B 183B 179B 7,782B EV / Sales 2026 *
4.96x
EV / Sales 2027 * 4.18x
Free-Float
61.59%
Yield 2026 *
0.66%
Yield 2027 * 0.67%
1 day+2.72%
1 week-9.39%
1 month-14.92%
3 months-3.59%
6 months-12.73%
Current year-6.58%
1 week 214
Extreme 214
251.5
1 month 214
Extreme 214
266.55
Current year 214
Extreme 214
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.72%-9.39%+17.04%+176.83% 48.89B
+3.29%+16.25%+39.81%+2.79% 76.15B
-2.75%+48.50%+48.50%+48.50% 47.83B
-3.81%+7.74%-54.57%-54.17% 41.37B
-2.40%+0.38%+58.55%-24.89% 29.99B
-2.82%+1.57%+59.59%+87.57% 24.23B
-5.35%+1.39%+85.45%-53.41% 21.75B
-1.59%-3.61%-11.53%+150.58% 19.25B
-0.42%+2.89%+74.55%+128.45% 17.14B
-2.50%-4.68%+69.43%+128.76% 15.66B
Average -1.94%+0.87%+38.68%+59.10% 34.22B
Weighted average by Cap. -1.54%+2.63%+32.51%+47.52%

Financials

2026 *2027 *
Net sales 8.56B 9.85B 7.97B 7.31B 13.81B 940B 14.03B 93.91B 36.86B 468B 36.98B 36.17B 1,569B 9.63B 11.08B 8.96B 8.23B 15.54B 1,058B 15.78B 106B 41.47B 527B 41.61B 40.69B 1,765B
Net income 1.81B 2.08B 1.68B 1.54B 2.92B 199B 2.96B 19.83B 7.78B 98.83B 7.81B 7.64B 331B 2.29B 2.63B 2.13B 1.96B 3.7B 252B 3.75B 25.13B 9.86B 125B 9.89B 9.68B 420B
Net Debt -46.42M -53.4M -43.21M -39.67M -74.92M -5.1B -76.08M -509M -200M -2.54B -201M -196M -8.51B -2.21B -2.55B -2.06B -1.89B -3.57B -243B -3.63B -24.29B -9.53B -121B -9.56B -9.35B -406B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-31 €222.90 +2.72% 497,579
26-07-30 €217.00 -13.51% 857,389
26-07-29 €250.90 +0.28% 171,258
26-07-28 €250.20 +1.79% 227,096
26-07-27 €245.80 -0.08% 136,709
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
222.90EUR
Average target price
287.21EUR
Spread / Average Target
+28.85%

Quarterly revenue - Rate of surprise